Kenneth Custer, President and General Manager of Eli Lilly Canada, gives insights into his background in neuroscience, innovation in healthcare, and progress in therapeutics for obesity and Alzheimer’s.

Jonathan Soong, General Manager of Amicus Therapeutics, gives insights into being at the forefront of rare disease innovations, patient support programs, and the importance of real world evidence for rare diseases.

Rodrigo Reis, General Manager of UCB Pharma Canada, gives insights into fostering innovation in pharma, collaborating with UHN to expedite diagnoses, and entering the rare disease space with new innovative therapeutics.

John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.

Brian Bloom, CEO of Bloom Burton & Co., gives insights into changes in the Canadian Healthcare investment landscape, the return of the generalist investor, and the rise of consumer empowerment in healthcare.

Rami Fayed, Vice President and General Manager of Canada at AbbVie, gives insights into patient support programs in Canada, diversifying therapeutic pipelines, and giving back to the community.

Jaclyn Katelnikof, Saskatchewan-based Pharmacist, gives insights into the patient-facing role of the pharmacist, the need for tech innovations in pharmacy, and the threats to the Canadian drug supply.

Milva D’Aronco, Founding Member at Women Leaders in Pharma, gives insights into the importance of mentorship, coaching women on confidence, and diversity as a profit-driver in the long term.